ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,860Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 124

$828K Total Retail Price of All Prescriptions

Rank: 3 out of 124

533 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 533 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 7,979 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 470 364 1 4
SIMVASTATIN 322 287 2 3
AMLODIPINE BESYLATE 290 246 3 1
OMEPRAZOLE 270 151 4 9
FUROSEMIDE 247 208 5 5
CRESTOR 241 171 6 22
CARVEDILOL 236 211 7 10
HYDROCODONE-ACETAMINOPHEN 214 138 S3 8 7
METFORMIN HCL 192 150 9 6
AZITHROMYCIN 190 146 10 23
HYDROCHLOROTHIAZIDE 186 159 11 11
TRAMADOL HCL-ACETAMINOPHEN 183 141 12 72
LISINOPRIL 181 128 13 2
NEXIUM 171 88 14 15
ATORVASTATIN CALCIUM 160 122 15 13
ALENDRONATE SODIUM 156 130 16 62
SPIRIVA 146 105 17 52
AMITRIPTYLINE HCL 135 131 R 18 43
SYNTHROID 126 88 19 70
JANUVIA 120 70 20 56
WARFARIN SODIUM 119 94 21 19
DIOVAN 107 107 22 27
LOSARTAN POTASSIUM 104 94 23 32
TRICOR 103 52 24 63
DIOVAN HCT 97 88 25 33
SULFAMETHOXAZOLE-TRIMETHOPRIM 94 65 26 50
LOVASTATIN 92 60 27 51
POTASSIUM CHLORIDE 91 80 28 21
AMLODIPINE BESYLATE-BENAZEPRIL 91 65 28 48
CITALOPRAM HBR 90 70 30 28
ESCITALOPRAM OXALATE 88 46 31 66
SINGULAIR 85 66 32 78
ADVAIR DISKUS 81 42 33 44
DONEPEZIL HCL 81 69 33 97
ALLOPURINOL 81 78 33 38
METOPROLOL SUCCINATE 81 44 33 14
ATENOLOL 79 78 37 29
METOPROLOL TARTRATE 77 62 38 12
RAMIPRIL 75 63 39 59
NIASPAN 71 34 40 107
GABAPENTIN 71 38 40 18
NAMENDA 70 65 42 116
LOSARTAN-HYDROCHLOROTHIAZIDE 70 57 42 53
MELOXICAM 67 52 44 16
CLOPIDOGREL 66 50 45 20
CYMBALTA 65 47 46 64
NATEGLINIDE 64 64 47 164
CYCLOBENZAPRINE HCL 63 35 R 48 49
TRAMADOL HCL 62 29 49 17
METFORMIN HCL ER 62 29 49 46
LANTUS SOLOSTAR 60 43 51 58
PLAVIX 57 43 52 31
LANTUS 56 50 53 47
MONTELUKAST SODIUM 55 41 54 127
DEXILANT 54 21 55 101
SERTRALINE HCL 53 35 56 37
FENOFIBRATE 53 29 56 81
ONGLYZA 52 34 58 134
DIGOXIN 52 52 58 76
ZOLPIDEM TARTRATE 50 39 60 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.